
PVLA EPS Estimates
Palvella Therapeutics, Inc.
$145.69
+$1.34(+0.93%)
45
Overall
40
Value
58
Tech
39
Quality
Market Cap
$2.13B
Volume
38.69K
52W Range
$72.23 - $179.95
Target Price
$231.06
PVLA EPS estimates: the consensus estimate for Palvella Therapeutics, Inc.'s current fiscal year is -$6.29 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
PVLA EPS Estimates
- EPS estimate, current quarter
- $-1.95
- EPS estimate, next quarter
- $-2.09
- EPS estimate, current year
- $-6.29
- EPS estimate, next year
- $-8.13
- EPS growth, 3-year
- -102.02%
| Fiscal year | EPS |
|---|---|
| 2025 | $-3.71 |
| 2024 | $-7.83 |
| 2023 | $-21.60 |
| 2022 | $-0.45 |
| 2021 | $-0.71 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PVLA | $145.69 | +0.9% | 38.69K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Palvella Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW